glp 1 and iih Metabolic pathogenesis treatment in IIH. is most prevalent in A Comprehensive Review of the

Working with a skilled menopause-trained clinician can help you determine if using semaglutide is something you should consider

Start your free physician assessment to determine if GLP-1 therapy is right for your specific situation and goals

AUD: alcohol use disorder

At the highest doses, retatrutide seems to promise more significant weight loss than existing GLP-1s on the market but as dosage increases, so does the risk of side effects, mostly mild-to-moderate gastrointestinal issues, although one case of pancreatitis occurred in a patient on the 12mg dose during the phase II trial

Rapid weight loss is a known risk factor for gallstone formation, as it alters the balance of bile components